This research mainly revealed that upon interaction with p53, BMI1 epigenetically repressed transcription of miR-3682-3p, which in turn increased P-GP expression, resulting in the enhanced drug efflux and chemoresistance of bladder cancer cells. Here, BMI1 is linked to urinary bladder cancer.